Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-19-000063
Filing Date
2019-04-24
Accepted
2019-04-23 18:08:58
Documents
10
Period of Report
2019-06-06
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A lgnd-2019annualmeetingproxy.htm DEF 14A 1394997
2 graph.jpg GRAPHIC 113635
3 image1a01.gif GRAPHIC 565
4 image2.gif GRAPHIC 1174
5 image3.gif GRAPHIC 612
6 image4.gif GRAPHIC 431
7 ligandlogo41719.jpg GRAPHIC 12141
8 ligandlogo41719a01.jpg GRAPHIC 12141
9 proxycard1of2.jpg GRAPHIC 350144
10 proxycard2of2.jpg GRAPHIC 225921
  Complete submission text file 0000886163-19-000063.txt   2362333
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 19762329
SIC: 2834 Pharmaceutical Preparations